FDA Inspection 1326756 - NORTHEAST BIOLAB - July 17, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore NORTHEAST BIOLAB

Record Details

This FDA Inspection record concerns NORTHEAST BIOLAB, with an inspection on July 17, 2026, issued by the New England District Office, covering human drugs.

Company: NORTHEAST BIOLAB
Inspection Date: July 17, 2026
Product Type: Human Drugs
Office: New England District Office

Open in Dashboard

ID · 775ac5bb-fc0a-4837-be6b-e1e405f36024

Violation Codes6

21 CFR 58.190(b)21 CFR 58.33(f)21 CFR 58.35(b)(7)21 CFR 58.81(a)21 CFR 58.81(c)21 CFR 58.83

Full citation text and observation details available on the Dashboard.